⌘K

Login Start Free

Home/Filings/4/0001415889-25-001312

4//SEC Filing

DeLucia David 4

Accession 0001415889-25-001312

CIK 0000921299other

View on SEC.gov Company Profile

Filed

Jan 9, 7:00 PM ET

Accepted

Jan 10, 6:16 PM ET

Size

5.4 KB

Accession

0001415889-25-001312

Insider Transaction Report

Form 4

Period: 2025-01-09

FIBROGEN INCFGEN

Chief Financial Officer

Transactions

Award
Stock Option (Right to Buy)
2025-01-09+525,000→ 525,000 total
Exercise: $0.65Exp: 2035-01-08→ Common Stock (525,000 underlying)

Footnotes (1)

[F1]The option vests in equal amount quarterly over 4 years measured from 1/9/2025.

Documents

1 file

4
form4-01102025_110123.xmlPrimary

Issuer

FIBROGEN INC

CIK 0000921299

Entity typeother

Related Parties

1

filerCIK 0002040705

Filing Metadata

Form type: 4
Filed: Jan 9, 7:00 PM ET
Accepted: Jan 10, 6:16 PM ET
Size: 5.4 KB

View on SEC.gov